Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic
- Product Overview:
Rat hemopressin is a bioactive peptide fragment derived from the hemoglobin ?1 chain. Hemopressin exhibits potent vasoactive biological activity, reducing rat blood pressure over a dosage range of 0.1-10 ?g/kg.{17293} This peptide is also a potent central cannabinoid (CB1) receptor antagonist conferring analgesia and pain relief or antinociception in vivo.{15127} Further studies will clarify the cellular and physiological effects of hemopressin, as well the possible products of endopeptidase activity on hemopressin.{17293,15127} This peptide is sparingly soluble in water and the following resuspension technique is recommended. Bring the peptide to room temperature and empty the contents of the vial into a 25 ml graduated cylinder. Use 1 mL serial aliquots of sterile filtered water to dissolve any remaining peptide in the glass vial to quantitatively transfer the total amount to the cylinder. Finally, add sterile filtered water to 20 ml final volume and mix gently to dissolve fully. One milligram of hemopressin dissolved in 20 ml water provides a 45.9 µM solution. One milligram per milliliter concentrations of hemopressin may also be prepared with the use of 10% methanol in water containing 0.1% trifluoroacetic acid.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.